Poniard Pharmaceuticals IncOver The Counter Market:PARD
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Poniard Pharmaceuticals Inc | 150.0 | 0.0x | --- |
Cantabio Pharmaceuticals Inc | 22.8K | 0.0x | --- |
FluoroPharma Medical Inc | 3.4K | 0.0x | --- |
Regenicin Inc | 15.4K | 0.0x | --- |
Baseline Productions Inc | 370.0 | 0.0x | --- |
Oncovista Innovative Therapies Inc | 2.4K | 0.0x | --- |
Company Information
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Contact Information
- Headquarters
- 750 Battery Street, Suite 330SAN FRANCISCO, CA, United States 94111
- Phone
- 206-286-2501
- Fax
- 206-284-2537
Executives
- Chairman of the Board
- Ronald Martell
- Independent Director
- Robert Basso
- Independent Director
- Frederick Craves
- Independent Director
- Carl Goldfischer
- Independent Director
- Robert Littauer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $150.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.5M |
Poniard Pharmaceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | $-11.92 |
Book Value | $6.96 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
